|
1
|
Xiao Q, Wang G, Yin X, Luo Z, Margariti A, Zeng L, Mayr M, Ye S, Xu Q. Chromobox Protein Homolog 3 Is Essential for Stem Cell Differentiation to Smooth Muscles In Vitro and in Embryonic Arteriogenesis. Arterioscler Thromb Vasc Biol 2011; 31:1842-52. [DOI: 10.1161/atvbaha.111.230110] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Affiliation(s)
- Qingzhong Xiao
- From the Centre for Clinical Pharmacology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom (Q. Xiao, S.Y.); Cardiovascular Division, King's College London British Heart Foundation Centre, London, United Kingdom (G.W., X.Y., Z.L., A.M., L.Z., M.M., Q. Xu)
| | - Gang Wang
- From the Centre for Clinical Pharmacology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom (Q. Xiao, S.Y.); Cardiovascular Division, King's College London British Heart Foundation Centre, London, United Kingdom (G.W., X.Y., Z.L., A.M., L.Z., M.M., Q. Xu)
| | - Xiaoke Yin
- From the Centre for Clinical Pharmacology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom (Q. Xiao, S.Y.); Cardiovascular Division, King's College London British Heart Foundation Centre, London, United Kingdom (G.W., X.Y., Z.L., A.M., L.Z., M.M., Q. Xu)
| | - Zhenling Luo
- From the Centre for Clinical Pharmacology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom (Q. Xiao, S.Y.); Cardiovascular Division, King's College London British Heart Foundation Centre, London, United Kingdom (G.W., X.Y., Z.L., A.M., L.Z., M.M., Q. Xu)
| | - Andriani Margariti
- From the Centre for Clinical Pharmacology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom (Q. Xiao, S.Y.); Cardiovascular Division, King's College London British Heart Foundation Centre, London, United Kingdom (G.W., X.Y., Z.L., A.M., L.Z., M.M., Q. Xu)
| | - Lingfang Zeng
- From the Centre for Clinical Pharmacology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom (Q. Xiao, S.Y.); Cardiovascular Division, King's College London British Heart Foundation Centre, London, United Kingdom (G.W., X.Y., Z.L., A.M., L.Z., M.M., Q. Xu)
| | - Manuel Mayr
- From the Centre for Clinical Pharmacology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom (Q. Xiao, S.Y.); Cardiovascular Division, King's College London British Heart Foundation Centre, London, United Kingdom (G.W., X.Y., Z.L., A.M., L.Z., M.M., Q. Xu)
| | - Shu Ye
- From the Centre for Clinical Pharmacology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom (Q. Xiao, S.Y.); Cardiovascular Division, King's College London British Heart Foundation Centre, London, United Kingdom (G.W., X.Y., Z.L., A.M., L.Z., M.M., Q. Xu)
| | - Qingbo Xu
- From the Centre for Clinical Pharmacology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom (Q. Xiao, S.Y.); Cardiovascular Division, King's College London British Heart Foundation Centre, London, United Kingdom (G.W., X.Y., Z.L., A.M., L.Z., M.M., Q. Xu)
| |
Collapse
|
|
2
|
Scrutinio D, Temporelli PL, Passantino A, Giannuzzi P. Long-term secondary prevention programs after cardiac rehabilitation for the reduction of future cardiovascular events: focus on regular physical activity. Future Cardiol 2009; 5:297-314. [DOI: 10.2217/fca.09.12] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023] Open
Abstract
Cardiac rehabilitation/secondary prevention programs are recognized as integral to the comprehensive care of patients with coronary heart disease, and as such are recommended in most contemporary clinical practice guidelines. The interventions are aimed at reducing disability, optimizing cardiovascular risk reduction by drug therapy and promoting healthy behavior. Healthy lifestyle habits must be recognized as capable of substantially reducing the risk for cardiovascular events in patients with coronary heart disease. This review highlights the recommended components of cardiac rehabilitation/secondary prevention programs, with special emphasis on regular physical activity.
Collapse
Affiliation(s)
- Domenico Scrutinio
- Fondazione ‘S. Maugeri’, IRCCS, Istituto di Cassano Murge, 70020 Cassano Murge (Bari), Italy
| | - Pier Luigi Temporelli
- ‘Salvatore Maugeri’ Foundation, IRCCS, Department of Cardiac Rehabilitation, Scientific Institutes of Veruno (NO), Italy
| | - Andrea Passantino
- Fondazione ‘S. Maugeri’, IRCCS, Istituto di Cassano Murge, 70020 Cassano Murge (Bari), Italy
| | - Pantaleo Giannuzzi
- ‘Salvatore Maugeri’ Foundation, IRCCS, Department of Cardiac Rehabilitation, Scientific Institutes of Veruno (NO), Italy
| |
Collapse
|